BMP-2 mRNA expression after endothelial progenitor cell therapy for fracture healing

Journal of Orthopaedic Trauma

Volumn 28, Issue SUPPL. 1, 2014, Pages

  Li, Ru ^a,b   Nauth, Aaron ^a   Gandhi, Rajiv ^b   Syed, Khalid ^b   Schemitsch, Emil H ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

angiogenesis; bone morphogenetic protein; endothelial progenitor cell; fracture healing; osteogenesis

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; GELFOAM; MESSENGER RNA; SODIUM CHLORIDE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MARROW; CELL CULTURE; CELL THERAPY; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; EX VIVO STUDY; FRACTURE HEALING; GENE EXPRESSION; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOGRAPHY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CELL- AND TISSUE-BASED THERAPY; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; FEMORAL FRACTURES; FEMUR; FRACTURE HEALING; MALE; RATS; RNA, MESSENGER; STEM CELL TRANSPLANTATION; STEM CELLS; TISSUE SCAFFOLDS;

EID: 84897113278     PISSN: 08905339     EISSN: 15312291     Source Type: Journal    
DOI: 10.1097/BOT.0000000000000071     Document Type: Article

References (21)

1. Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res. 1999; 85:221-228. (Pubitemid 29377293)
2. Takahashi T, Kalka C, Masuda H, et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med. 1999;5:434-438. (Pubitemid 29180584)
3. Kalka C, Masuda H, Takahashi T, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A. 2000;97:3422-3427. (Pubitemid 30183318)
4. Atesok K, Li R, Stewart DJ, et al. Endothelial progenitor cells promote fracture healing in a segmental bone defect model. J Orthop Res. 2010; 28:1007-1014.
5. Mifune Y, Matsumoto T, Kawamoto A, et al. Local delivery of granulocyte colony stimulating factor-mobilized CD34-positive progenitor cells using bioscaffold for modality of unhealing bone fracture. Stem Cells. 2008;26:1395-1405.
6. Rozen N, Bick T, Bajayo A, et al. Transplanted blood-derived endothelial progenitor cells (EPC) enhance bridging of sheep tibia critical size defects. Bone. 2009;45:918-924.
7. Li R, Atesok K, Nauth A, et al. Endothelial progenitor cells for fracture healing: a microcomputed tomography and biomechanical analysis. J Orthop Trauma. 2011;25:467-471.
8. Nauth A, Ristevski B, Li R, et al. Growth factors and bone regeneration: how much bone can we expect? Injury. 2011;42:574-579.
9. Giannoudis PV, Einhorn TA. Bone morphogenetic proteins in musculoskeletal medicine. Injury. 2009;40(suppl 3):S1-S3.
10. Jin Y, Yang L, White FH. An immunocytochemical study of bone morphogenetic protein in experimental fracture healing of the rabbit mandible. Chin Med Sci J. 1994;9:91-95.
11. Nakase T, Nomura S, Yoshikawa H, et al. Transient and localized expression of bone morphogenetic protein 4 messenger RNA during fracture healing. J Bone Miner Res. 1994;9:651-659. (Pubitemid 24130466)
12. Lieberman JR, Daluiski A, Stevenson S, et al. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J Bone Joint Surg Am. 1999;81:905-917. (Pubitemid 29354999)
13. Hsu WK, Sugiyama O, Park SH, et al. Lentiviral-mediated BMP-2 gene transfer enhances healing of segmental femoral defects in rats. Bone. 2007;40:931-938. (Pubitemid 46386528)
14. Cowan CM, Aghaloo T, Chou YF, et al. MicroCT evaluation of threedimensional mineralization in response to BMP-2 doses in vitro and in critical sized rat calvarial defects. Tissue Eng. 2007;13:501-512. (Pubitemid 46579877)
15. Nie H, Ho ML, Wang CK, et al. BMP-2 plasmid loaded PLGA/HAp composite scaffolds for treatment of bone defects in nude mice. Biomaterials. 2009;30:892-901.
16. Kawamoto A, Gwon HC, Iwaguro H, et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation. 2001;103:634-637. (Pubitemid 32144189)
17. Taguchi A, Soma T, Tanaka H, et al. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest. 2004;114:330-338. (Pubitemid 39071605)
18. Murayama T, Tepper OM, Silver M, et al. Determination of bone marrowderived endothelial progenitor cell significance in angiogenic growth factorinduced neovascularization in vivo. Exp Hematol. 2002;30:967-972. (Pubitemid 34838899)
19. Urbich C, Aicher A, Heeschen C, et al. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol. 2005;39:733-742. (Pubitemid 41464410)
20. Kumar S, Wan C, Ramaswamy G, et al. Mesenchymal stem cells expressing osteogenic and angiogenic factors synergistically enhance bone formation in a mouse model of segmental bone defect. Mol Ther. 2010;18:1026-1034.
21. Granero-Molto F, Weis JA, Miga MI, et al. Regenerative effects of transplanted mesenchymal stem cells in fracture healing. Stem Cells. 2009;27: 1887-1898.